// Definition
A standardised sublingual cannabis formulation system developed by United Cannabis and presented by Tony Verzura. Five formulations designed for different medical applications: P1 (THCA-dominant), P2 (high CBD ratios), P3 (balanced THC:CBD), P4 (CBD:CBN for sleep), and P5 (raw/acidic cannabinoids). Each formulation includes electronic health record (EHR) patient tracking to build clinical data around specific cannabinoid ratios and patient outcomes.
// From the Episode
The P1-P5 system was presented by Tony Verzura in Episode 3 as an attempt to bring pharmaceutical-level standardisation to cannabis medicine. Each formulation targets a specific therapeutic profile: P1 uses THCA (the acid form, non-psychoactive) for patients who need cannabinoid support without intoxication. P2 emphasises CBD ratios for conditions like epilepsy and anxiety. P3 balances THC and CBD for pain management. P4 combines CBD with CBN specifically for sleep disorders. P5 preserves raw, acidic cannabinoids for patients exploring the therapeutic potential of undecarboxylated cannabis. The EHR integration was presented as revolutionary — tracking which formulation, at what dose, produces what outcome for each patient, building the clinical evidence base that cannabis medicine has historically lacked. One example discussed was a child with autism using P2/P4 drops at 6-8mg per day, costing just $1.30 daily.
// Source
Ep. 003 Hash Church Episode III →